-The Economic Times Japanese companies do not mind erring on the side of caution. They are known to think longer and harder than their counterparts in other countries about big decisions, especially when it comes to entering a new market or acquiring a foreign company. But Japan's third biggest drugmaker Daiichi Sankyo would now wish it had spent more time doing due diligence on Ranbaxy Labs, in which it bought a...
More »SEARCH RESULT
Total Matching Records found : 725
Tamil Nadu bans gutka, pan masala -R Satyanarayana
-The Times of India CHENNAI: The Tamil Nadu government has decided to ban the production, stocking, distribution and sale of tobacco products such as gutka and pan masala in the state. The decision came in the backdrop of the Supreme Court's remarks in a case recently, seeking to know the action taken by state governments in curbing the use of tobacco and its products. The order will be passed in a...
More »Former WB economist to lead Cornell poverty India initiative
-PTI Pingali has been appointed director of the Tata-Cornell Initiative in Agriculture and Nutrition Washington: Former World Bank economist Prabhu Pingali has been appointed by the Cornell University to lead effort to help reduce poverty and malnutrition in India, a project established through a USD 25 million endowment from the Tata Trusts. Pingali has been appointed director of the Tata-Cornell Initiative in Agriculture and Nutrition (TACO-AN), a long-term project established through a...
More »Fear of nuclear disaster has no basis: court-J Venkatesan
-The Hindu The Supreme Court on Monday said there is no basis to the fear that the radioactive effects of the Kudankulam nuclear power plant, when commissioned, will be far reaching. A Bench of Justices K.S. Radhakrishnan and Dipak Misra said: "We are convinced that the KKNPP design incorporates advanced safety features complying with the current standards of redundancy, reliability, independence and prevention of common cause failures in its safety systems....
More »Johnson & Johnson’s licence for cosmetics cancelled -Jyoti Shelar
-Mumbai Mirror The Food and Drug Administration (FDA) recently cancelled Johnson & Johnson India's licence to produce cosmetic products at their Mulund plant. FDA's order will come into effect from June 24. According to FDA officials, the order was issued in a case dating back to 2007 when they found that 15 batches of Johnson & Johnson baby powder were sterilised by ethylene oxide, a known carcinogenic and irritant. "While ethylene oxide can...
More »
